Avicanna Reports Q2 2023 Financial Statement
15 août 2023 07h30 HE
|
Avicanna Inc.
TORONTO, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and...
Avicanna Announces Closing of Non-Brokered Private Placement of Debenture Units
02 août 2023 19h50 HE
|
Avicanna Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES...
Avicanna Announces Closing of Acquisition and Launch of MyMedi.ca
01 août 2023 07h30 HE
|
Avicanna Inc.
Completed the acquisition of the Medical Cannabis by Shopper’s Drug Mart business. Launch of Avicanna’s new medical cannabis care platform MyMedi.ca. TORONTO, Aug. 01, 2023 (GLOBE NEWSWIRE) --...
Avicanna is Pleased to Announce the Initial Network of Brands on the MyMedi.ca Platform
28 juil. 2023 07h30 HE
|
Avicanna Inc.
The MyMedi.ca medical cannabis care platform is preparing to launch August 1, 2023 The new cannabis care platform will offer a diverse portfolio of products, including 35 brands and over 200 SKUs...
Avicanna Subsidiary SMGH Exports Aureus Branded CBD and CBG Into Paraguay
17 juil. 2023 07h30 HE
|
Avicanna Inc.
TORONTO, July 17, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
Avicanna Provides Corporate Update and Preliminary Q2 Results
28 juin 2023 07h30 HE
|
Avicanna Inc.
TORONTO, June 28, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...
Avicanna and Medipharm Labs Expand Strategic Manufacturing Agreement for Avicanna’s Proprietary SEDDS Technology Capsules for Canadian and International markets
26 juin 2023 07h30 HE
|
Avicanna Inc.
Avicanna’s proprietary SEDDS technology capsules are designed for enhanced and rapid absorption of cannabinoids. Avicanna and Medipharm intend to commercialize various formulations of Avicanna’s...
Avicanna Sponsors New Medical Cannabis Education and Training Campaign in Canada with the Canadian Consortium for the Investigation of Cannabinoids (“CCIC”)
22 juin 2023 07h30 HE
|
Avicanna Inc.
TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a commercial stage, international biopharmaceutical company focused on...
Avicanna and Langara College Announce Cannabinoid-Based Translational Research Collaboration and NSERC Grant
13 juin 2023 07h30 HE
|
Avicanna Inc.
This Research Collaboration will be led by Dr. Jessica Kalra’s research team and focus on characterization of Avicanna’s proprietary products and drug pipeline formulations This Research...
Shoppers Drug Mart and Avicanna Execute Definitive Asset Purchase Agreement for Avicanna’s Acquisition of the Medical Cannabis by Shoppers Business
29 mai 2023 07h30 HE
|
Avicanna Inc.
TORONTO, May 29, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or the “Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and...